The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis. (Q53121710)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

decision analysis

1 reference

based on heuristic

inferred from title

author name string

S Kako

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

S Morita

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

H Sakamaki

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

H Iida

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

M Kurokawa

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

K Miyamura

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

H Kanamori

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

M Hara

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

N Kobayashi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

Y Morishima

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

K Kawa

11

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

T Kyo

12

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

T Sakura

13

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

I Jinnai

14

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

J Takeuchi

15

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

Y Miyazaki

16

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

S Miyawaki

17

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

K Ohnishi

18

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

T Naoe

19

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

Y Kanda

20

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

language of work or name

0 references

publication date

4 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

48

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

1077-1083

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Adolescents and young adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Outcome Analysis and Study of the Impact of Hematopoietic Graft Source

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

21 January 2018

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcomes in adult patients below the age of 55 years with acute lymphoblastic leukemia treated with chemotherapy or allogeneic BM transplant in first CR

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: update of the 2006 evidence-based review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2013.4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/23376818

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53121710&oldid=2212000687"